M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 51.06 USD -1.6%
Market Cap: 3.3B USD
Have any thoughts about
MoonLake Immunotherapeutics?
Write Note

MoonLake Immunotherapeutics
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MoonLake Immunotherapeutics
Accrued Liabilities Peer Comparison

Comparables:
ADCT
ACIU
CRSP
MOLN
XLS

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
M
MoonLake Immunotherapeutics
NASDAQ:MLTX
Accrued Liabilities
$8.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Accrued Liabilities
$39.1m
CAGR 3-Years
48%
CAGR 5-Years
51%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Accrued Liabilities
CHf11.9m
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Accrued Liabilities
$64.1m
CAGR 3-Years
-7%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Molecular Partners AG
SIX:MOLN
Accrued Liabilities
CHf6.7m
CAGR 3-Years
-12%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Xlife Sciences AG
SIX:XLS
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MoonLake Immunotherapeutics's Accrued Liabilities?
Accrued Liabilities
8.1m USD

Based on the financial report for Dec 31, 2023, MoonLake Immunotherapeutics's Accrued Liabilities amounts to 8.1m USD.

What is MoonLake Immunotherapeutics's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 1Y
10%

Over the last year, the Accrued Liabilities growth was 10%.

Back to Top